Blog - Page 3254 of 5681

TuesdayFeb 14, 2012 1:44 pm

Grizzly Discoveries, Inc. (GZDIF) (GZD.V) is “One to Watch”

Grizzly Discoveries is a Canadian exploration company that lists on the OTCQX and TSX Venture Exchange. The company focuses on exploring for potash in Alberta; world-class gold and base metal deposits in British Columbia; and diamonds in Alberta. Grizzly holds, or has an interest in, metallic and industrial mineral permits for potash totalling more than 2.34 million acres along the Alberta-Saskatchewan border. The U.S. Geological Survey's assessment indicates that the Potash Mineable Area continues into Alberta from Saskatchewan. The company is targeting a 250-500 million tonne (mt) deposit which at 20 percent K2O would generate a 50 -100 mt Potash…

TuesdayFeb 14, 2012 9:30 am

GlobalWise Investments, Inc. (GWIV) Finalizes Intellinetics Acquisition

Today before the opening bell, GlobalWise Investments, Inc. announced the completion of its acquisition of Intellinetics, Inc. (www.Intellinetics.com). Intellinetics is now a wholly owned subsidiary of GlobalWise Investments. Intellinetics is a leading-edge technology company focused on Enterprise Content Management (ECM) solutions for the digital age. Leveraging its cloud-based computing software, GlobalWise Investments is poised to capture a significant market share of the burgeoning ECM industry. The Intellinetics platform combines advanced virtualization and automated content management with an open and service-oriented architecture using Web services. The company provides strategies, tactics and technologies to manage paper and digital assets from capture to…

MondayFeb 13, 2012 5:38 pm

Celsion Corp. (CLSN) Enrolls First Patient in Phase II Study for Colorectal Liver Metastases Treatment

Leading oncology drug development company Celsion Corp. today announced it has enrolled its first patient in a randomized phase II study of ThermoDox, the company’s lead product candidate. ThermoDox is a heat-activated liposomal encapsulation of doxorubicin that, in combination with radiofrequency ablation (RFA), is being tested for the treatment of colorectal liver metastases (CRLM). Up to 88 patients diagnosed with colorectal cancer metastasized to the liver are expected to be enrolled in the multicenter phase II study. The patients will be randomized to receive liver tumor treatment that is either includes RFA plus ThermoDox or RFA alone. Leading North American…

MondayFeb 13, 2012 4:27 pm

Lithium Exploration Group (LEXG) Issues Update on Exploratory Mining Activity

Lithium Exploration Group issued an operational update on the company’s mineral exploration activity at various properties under review. The company properties are prospective for lithium, potassium, magnesium, and other resources. Lithium Exploration is currently working on the final draft of the 43-101 Technical Report, which details the level of potential resources on the company’s Valleyview Project in Alberta, Canada. The company is consulting with the regulatory authorities and will publish the technical report after these consultations are complete. Lithium Exploration recently added additional acreage nearby the company’s leasehold at the Valleyview Project, bringing its total position to 650,000 net acres.…

MondayFeb 13, 2012 4:24 pm

MedPro Safety Products, Inc. (MPSP) Survey Finds Ample Support for their Prefilled Cartridge Safety Syringe Drug Delivery Platform

Today, MedPro Safety Products, the Lexington, Kentucky-based developer of innovative safety-focused products that cut across multiple product categories in medication delivery and blood collection, reported that the results of a recent survey of 497 pharmacy professionals (conducted at the American Society of Health System Pharmacists Mid-Year Clinical Meeting in Dec 2011) suggest significant interest exists for a new pre-filled drug delivery platform. These results are excellent news for MPSP, which has developed an impressive array of medical devices/products for phlebotomy and drug delivery applications. MPSP products are designed to incorporate automatic and/or semi-automatic activation systems, a feature which has been…

MondayFeb 13, 2012 1:50 pm

Intellicheck Mobilisa, Inc. (IDN) Secures Contract with Major International Banking Firm

Intellicheck Mobilisa is engaged in developing and marketing wireless technology and identity systems for various applications, including mobile and handheld access control and security systems for the government, military, and commercial markets. Today, Intellicheck announced they have signed a contract with a major international banking firm. The value of the contract is for $600,000, and has the potential to make Intellicheck an even larger competitor within their sector. Intellicheck will have their patented ID Check software integrated with the international banking firm’s bank teller transaction system. ID Check software instantly reads, analyzes, and verifies the encoded data in barcodes and…

MondayFeb 13, 2012 12:19 pm

FluoroPharma Medical, Inc. (FPMI) Continues to Move New Products Forward

Turning a good idea into a money making product can be a formidably expensive project, especially when dealing with medical substances to be introduced to the human body. FluoroPharma, developer of medical diagnostic imaging agents for use with PET (positron emission tomography) scanning, is believed to be in a strong position to accomplish exactly that with its two primary imaging assets, CardioPET and BFPET. CardioPET is an imaging agent designed for cardiac viability assessment, detecting regions of metabolic insufficiency. BFPET is designed for myocardial perfusion imaging, measuring cardiovascular blood flow. The company is about to take both of these products…

MondayFeb 13, 2012 11:41 am

PositiveID (PSID) Achieves Positive Preliminary Results for Glucose-sensing Diabetes Device

PositiveID Corp., a developer of medical technologies for diabetes management, today announced that preliminary results from its biotransport research study with the Diabetes Research Institute (DRI) at the University of Miami demonstrate positive data for the company’s GlucoChip ™. PositiveID's GlucoChip is a glucose-sensing implantable microchip, currently under development with RECEPTORS LLC, for individuals with diabetes. The company reports that preliminary results demonstrate that the membrane materials to be used with GlucoChip allow for successful movement of glucose from body fluids. "These first studies were successfully completed with the demonstration that a glucose tracer readily enters the device from surrounding…

MondayFeb 13, 2012 11:30 am

Clean Diesel Technologies, Inc. (CDTI) Receives Expanded California Approval for Emissions Reduction System

Clean Diesel Technologies is a global manufacturer and distributor of emissions control systems and products focused on the heavy duty diesel and light duty vehicle markets. One of the company's main products is its ECS purifilter brand emission reduction product. The company today announced that the California Air Reources Board (CARB) has expanded their approval of Clean Diesel's ECS Purifilter emission reduction product to now include larger control devices aimed at heavy duty on-road vehicle engines up to 16 liters and 625 horsepower. This market will include not only heavy duty trucks, but also municipal vehicles as well as school…

MondayFeb 13, 2012 11:01 am

OncoSec Medical Inc. (ONCS) Video Chart for Monday, February 13, 2012

ONCS has made a stellar move off the bottom over the last few months. The stock's price has consolidated after the climb and is holding the majority of the gains. A thinly-traded stock, little pressure could move it in either direction, but it's on radar to take out resistance at 80 cents. To view the video chart, visit the following link: http://www.qualitystocks.net/videocharts Let us hear your thoughts below:

Site Search

Company Search